Growth hormone status in morbidly obese subjects and correlation with body composition.
Morbidly obese subjects are characterized by multiple endocrine abnormalities and these are paralleled by unfavorable changes in body composition. In obese individuals, either 24-h spontaneous or stimulated GH secretion is impaired without an organic pituitary disease and the severity of the secretory defect is proportional to the degree of obesity. The GHRH+arginine (GHRH+ARG) test is likely to be the overall test of choice in clinical practice to differentiate GH deficiency (GHD) patients. Similarly to other provocative tests, GHRH+ARG is influenced by obesity per se. Therefore, a new cut-off limit of peak GH response of 4.2 microg/l in obese subjects has been recently assumed. The aim of the present study was to investigate the reciprocal influence between decreased GH secretion and body composition in a group of 110 morbidly obese subjects, using the new cut-off limit of peak GH response to GHRH+ARG test for these subjects. In our study, GHD was identified in 27.3% of the obese subjects, without gender difference. In GDH obese subjects body mass index (BMI), waist circumference, waist-to-hip ratio (WHR), fat mass (FM), and resistance (R) were higher while reactance (Xc), phase angle, body cell mass (BCM), IGF-I, or IGF-I z-scores were lower than in normal responders (p<0.001). In all obese subjects, GH peak levels showed a negative correlation with age, BMI, waist circumference and FM, and a positive correlation with IGF-I. In the stepwise multiple linear regression, waist circumference and FM were the major determinants of GH peak levels and IGF-I. In conclusion, using the new cut-off limit of peak GH response to GHRH+ARG test for obese subjects, about 1/3 morbidly obese subjects were GHD. GHD subjects showed a significantly different body composition compared with normal responders, and the secretory defect was correlated to different anthropometric variables with waist circumference and FM as the major determinants.
Savastano
S
S
Division of Endocrinology, Department of Molecular and Clinical Endocrinology and Oncology, University Federico II, Naples, Italy. sisavast@unina.it
Di Somma
C
C
Belfiore
A
A
Guida
B
B
Orio
F
F
Rota
F
F
Savanelli
M C
MC
Cascella
T
T
Mentone
A
A
Angrisani
L
L
Lombardi
G
G
Colao
A
A
D000273:Adipose Tissue / Q000033:anatomy & histology; D000328:Adult; D000886:Anthropometry; D001120:Arginine; D001823:Body Composition / Q000502:physiology*; D015992:Body Mass Index; D017097:Electric Impedance; D005260:Female; D013007:Growth Hormone-Releasing Hormone; D019382:Human Growth Hormone / Q000097:blood* / Q000172:deficiency / Q000378:metabolism; D006801:Humans; D008297:Male; D009767:Obesity, Morbid / Q000503:physiopathology*; D012044:Regression Analysis; D049629:Waist-Hip Ratio
D019382:Human Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D001120:Arginine